| 31.225 -0.145 (-0.46%) | 12-05 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 37.37 |
1-year : | 43.65 |
| Resists | First : | 32 |
Second : | 37.37 |
| Pivot price | 30.64  |
|||
| Supports | First : | 30.06 |
Second : | 28.87 |
| MAs | MA(5) : | 31.25 |
MA(20) : | 30.59 |
| MA(100) : | 31.59 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 76.6 |
D(3) : | 76 |
| RSI | RSI(14): 51.2 |
|||
| 52-week | High : | 35.72 | Low : | 24.47 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ HEAL ] has closed below upper band by 35.3%. Bollinger Bands are 76.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 20 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 31.64 - 31.83 | 31.83 - 31.99 |
| Low: | 30.73 - 30.93 | 30.93 - 31.11 |
| Close: | 30.94 - 31.26 | 31.26 - 31.54 |
HEAL aims to focus on tech-driven innovation in the healthcare sector. As such, the fund seeks to provide exposure to firms looking to shape the future of healthcare by improving patient outcomes and driving medical breakthroughs. Companies around the world, including ADRS, that engage in healthcare analytics and software, smart medical devices, AI-enabled drug discovery, and tech-enabled consumer healthcare. The underlying index screens for companies that are found in FactSet industries identified by the index administrator as relating to healthcare technology and derive at least 50% of their revenue from one or more of the subthemes. Prior to April 1, 2025, the fund tracked a narrower index targeting telemedicine and digital health, the Solactive Telemedicine & Digital Health Index. The fund name was Global X Telemedicine & Digital Health ETF and traded using the ticker EDOC.
Wed, 03 Dec 2025
Long-Term Care and Dementia-Oriented Stocks: A Tactical Safeguard Against Rising Healthcare Expenses - Bitget
Wed, 19 Nov 2025
Global X HealthTech ETF (NASDAQ:HEAL) Stock Price Up 0.8% – Should You Buy? - Defense World
Thu, 18 Sep 2025
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs - Benzinga
Wed, 10 Sep 2025
Investing in the Future of Healthcare - ETF Trends
Mon, 18 Aug 2025
Global X Announces Five ETF Reverse Stock Splits - PR Newswire
Wed, 23 Apr 2025
The Next Big Theme: April 2025 - Global X ETFs
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|